esmolol has been researched along with Cardiovascular Stroke in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (19.05) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 15 (35.71) | 29.6817 |
| 2010's | 8 (19.05) | 24.3611 |
| 2020's | 2 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Aljundi, A; Alyafei, S; Kasem, M; Mahfouz, A; Omar, AS; Rahhal, A | 1 |
| Assling-Simon, L; Boengler, K; Böning, A; Grieshaber, P; Heep, M; Komguem, A; Mühlfeld, C; Niemann, B; Schipke, J; Veitinger, AB | 1 |
| Funao, T; Kawai, S; Matsuura, T; Nishikawa, K; Yamada, T | 1 |
| Ollila, A; Pettilä, V; Sund, R; Vikatmaa, L; Wilkman, E | 1 |
| Guo, Z; Han, SQ; Han, Y; Liu, T; Wang, LL | 1 |
| Chan, KH; Chan, MY; Fujise, K; Huang, MH; Lee, CH; Low, AF; Lui, CY; Nguyen, V; Poh, KK; Sia, W; Tan, HC; Tang, LQ; Tay, EL; Xu, X | 1 |
| Buchholz, B; Del Mauro, JS; Deutsch, ACR; Donato, M; Gelpi, RJ; Höcht, C; Perez, V; Rodríguez, M | 1 |
| Biesenbach, E; Caglayan, E; Dahlem, KM; Er, F; Erdmann, E; Gassanov, N; Hellmich, M; Herrfurth, T; Kuhr, K; Le, MT; Nia, AM; Taghiyev, Z | 1 |
| Biesenbach, E; Caglayan, E; Dahlem, KM; Er, F; Eran-Ergöknil, A; Erdmann, E; Gassanov, N; Hellmich, M; Herrfurth, T; Kuhr, K; Le, MT; Nia, AM; Taghiyev, Z; Vanezi, M; Waltenberger, J; Yüksel, D | 1 |
| Irwin, MG; Xia, Z | 1 |
| Baldassarri, R; Guarracino, F; Landoni, G; Nobile, L; Stefani, M | 1 |
| Aggarwal, KB; Allenby, KS; Ben-Yehuda, O; Chang, CT; Labovitz, AJ; Loyd, R; Mitchell, RG; Stoddard, MF; Trillo, RA | 1 |
| Geissler, HJ | 1 |
| Bukhvalov, VA; Petrik, ES; Shabalkov, EA; Shalaev, SV | 1 |
| Arora, N; Bhattacharjee, J; Chaudhary, M; Daga, MK; Ghambhir, DS; Sharma, B; Sudha, R | 1 |
| Cabo, C; Coromilas, J; Kassotis, J; Sauberman, RB; Wit, AL | 1 |
| Andreadou, I; Bofilis, E; Cokkinos, P; Iliodromitis, EK; Kremastinos, DT; Tasouli, A; Zoga, A | 1 |
| Dzhaiani, NA; Golubev, AV; Kochetov, AG; Kositsyna, IV; Tereshchenko, SN | 1 |
| Alhashemi, JA | 1 |
| Goyagi, T; Kimura, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Blomeyer, CA; Kehl, F; Klotz, KN; Lange, M; Redel, A; Roewer, N; Smul, TM | 1 |
| Grigoriadis, A; Koutouzis, M; Koutsogeorgis, D; Kyriakides, ZS; Nikolidakis, S | 1 |
| Riess, ML; Stowe, DF | 1 |
| Anderson, WG; Borgman, RJ; Erhardt, PW; Gorczynski, RJ; Kam, ST; Lee, RJ; O'Donnell, JP; Reynolds, RD; Zaroslinski, J | 1 |
| Braunwald, E; Kloner, RA; Lange, R | 1 |
| Appunn, DO; Barbier, GH; Shettigar, UR | 1 |
| Fusilli, L; Lee, W; Patel, J; Regan, TJ | 1 |
| Hilleman, DE; Hunter, CB; Mohiuddin, SM; Mooss, AN | 1 |
| Karski, JM; Redahan, C | 1 |
| Anderson, WA; Daloisio, C; Fernandez, J; Gu, J; Laub, GW; McGrath, LB; Mulligan, LJ; Muralidharan, S; Reibman, J | 1 |
| Imagawa, H; Kadoba, K; Masai, T; Matsuda, H; Sawa, Y; Takahashi, T; Taniguchi, K | 1 |
| Douglas, PS; Ginsburg, GS; Joffe, II; Katz, SE; Riley, MF | 1 |
| Borowski, A; Korb, H | 1 |
| Harmoinen, A; Kaukinen, S; Rinne, T | 1 |
| Allen, SJ; Brennan, ML; Buja, LM; Davis, KL; Geissler, HJ; Laine, GA; Mehlhorn, U | 1 |
| Caracciolo, E; Chinitz, L; Demopoulos, L; Perez, J; Schrem, S; Schwartzman, D; Slater, W | 1 |
| Kirshenbaum, JM | 1 |
| van Wezel, HB | 1 |
| Antman, EM; Braunwald, E; Kirshenbaum, JM; Kloner, RA | 1 |
| Antman, EM; Braunwald, E; Kirshenbaum, J; Kloner, RA; Lange, R | 1 |
| Gorczynski, RJ; Quon, CY; Reynolds, RD | 1 |
| Angaran, DM; Schultz, NJ; Tschida, VH | 1 |
7 review(s) available for esmolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Successful Use of Intravenous B-blocker Therapy in Cardiogenic Shock Supported With Venoarterial Extracorporeal Membrane Oxygenation: A Case Series.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactates; Myocardial Infarction; Propanolamines; Shock, Cardiogenic | 2022 |
Efficacy and safety of intravenous esmolol for cardiac protection in non-cardiac surgery. A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Bradycardia; Female; Heart; Heart Diseases; Hemodynamics; Humans; Hypotension; Male; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Propanolamines; Protective Agents; Randomized Controlled Trials as Topic; Safety | 2019 |
Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Heart Rate; Humans; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic; Research Design | 2015 |
Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Clinical Trials as Topic; Electrophysiology; Heart Rate; Humans; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Propanolamines; Reperfusion Injury; Tachycardia, Supraventricular | 1995 |
Nonthrombolytic intervention in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Humans; Myocardial Infarction; Nitrates; Prognosis; Propanolamines; Vasodilator Agents | 1989 |
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Dogs; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; Oxygen Consumption; Propanolamines; Syndrome; Time Factors | 1985 |
Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Coronary Disease; Drug Interactions; Female; Heart; Hemodynamics; Humans; Hypertension; Kinetics; Lactation; Myocardial Infarction; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Tachycardia | 1986 |
10 trial(s) available for esmolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.
Topics: Blood Pressure; Drug Therapy, Combination; Electrocardiography; Heart Rate; Humans; Infusions, Intravenous; Milrinone; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Propanolamines | 2014 |
Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Biomarkers; Creatine Kinase; Female; Germany; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Percutaneous Coronary Intervention; Prognosis; Propanolamines; Prospective Studies; Shock, Cardiogenic; Single-Blind Method; Tachycardia, Ventricular; Troponin T | 2016 |
Esmolol in acute ischemic syndromes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina, Unstable; Calcium Channel Blockers; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Patient Selection; Propanolamines; Prospective Studies | 2002 |
[The use of a beta-blocker esmolol in patients with acute myocardial infarction treated with streptokinase].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Propanolamines | 2002 |
Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Antioxidants; Double-Blind Method; Female; Free Radicals; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidants; Propanolamines; Prospective Studies | 2003 |
[The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure].
Topics: Adrenergic beta-Antagonists; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Atrial Function, Right; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance | 2006 |
Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Contraindications; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Thrombolytic Therapy; Time Factors | 1994 |
Esmolol cardioplegia in unstable coronary revascularisation patients. A randomised clinical trial.
Topics: Adrenergic beta-Antagonists; Aged; Cardioplegic Solutions; Coronary Artery Bypass; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Humans; Lactic Acid; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Myoglobin; Postoperative Complications; Propanolamines; Prospective Studies; Troponin | 2000 |
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Dogs; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; Oxygen Consumption; Propanolamines; Syndrome; Time Factors | 1985 |
26 other study(ies) available for esmolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardioprotection with esmolol-based cardioplegia for non-infarcted and infarcted rat hearts.
Topics: Animals; Cardioplegic Solutions; Heart Arrest, Induced; Myocardial Infarction; Propanolamines; Rats | 2021 |
Neuropathic pain attenuates ischemia reperfusion injury through β2-adrenergic pathway.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Hemodynamics; Hyperalgesia; Isolated Heart Preparation; Ligation; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocytes, Cardiac; Neuralgia; Phosphotransferases; Propanolamines; Protective Factors; Rats; Reperfusion Injury; Spinal Cord | 2017 |
Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Occlusion; Drug Evaluation, Preclinical; Gene Expression; Male; Myocardial Infarction; Myocardium; Neurokinin-1 Receptor Antagonists; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Neurokinin-1; Substance P | 2013 |
Changes in the loading conditions induced by vagal stimulation modify the myocardial infarct size through sympathetic-parasympathetic interactions.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Atropine; Catecholamines; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Proto-Oncogene Proteins c-akt; Rabbits; Reflex; Signal Transduction; Sympathetic Nervous System; Vagus Nerve | 2015 |
Esmolol may abolish volatile anesthetic-induced postconditioning by scavenging reactive oxygen species.
Topics: Adrenergic beta-Antagonists; Anesthetics, Inhalation; Animals; Cardiotonic Agents; Free Radical Scavengers; Myocardial Infarction; Propanolamines; Rabbits; Reactive Oxygen Species; Reperfusion Injury | 2009 |
Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan | 2010 |
Reduction of myocardial reperfusion injury by high-dose beta-blockade with esmolol.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Cardiopulmonary Bypass; Dogs; Dose-Response Relationship, Drug; Edema, Cardiac; Heart Arrest, Induced; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Propanolamines; Ventricular Function, Left | 2002 |
Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Dogs; Drug Synergism; Electrocardiography; Heart Conduction System; Myocardial Infarction; Propanolamines; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2003 |
Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Hemodynamics; Infusions, Intravenous; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Rabbits; Survival Rate; Time Factors | 2004 |
Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan | 2005 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carvedilol; Halothane; Ischemic Attack, Transient; Male; Morpholines; Myocardial Infarction; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Urea | 2006 |
Role of the beta1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo.
Topics: Anesthetics; Animals; Blood Pressure; Cyclic AMP-Dependent Protein Kinases; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Potassium Channels; Propanolamines; Rabbits; Receptors, Adrenergic, beta-1; Signal Transduction | 2006 |
beta-Blockade abolishes anesthetic preconditioning: impact on clinical applicability.
Topics: Adrenergic beta-Antagonists; Anesthetics, Inhalation; Animals; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Propanolamines; Rabbits | 2007 |
Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Heart Diseases; In Vitro Techniques; Myocardial Infarction; Propanolamines; Time Factors | 1982 |
First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Coronary Circulation; Dogs; Heart Rate; Hemodynamics; Infusions, Parenteral; Myocardial Contraction; Myocardial Infarction; Myocardium; Propanolamines | 1983 |
Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Disease Models, Animal; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Propanolamines; Ventricular Fibrillation | 1994 |
Thyrotoxicosis factitia in a post-aortocoronary bypass patient.
Topics: Adrenergic beta-Antagonists; Amrinone; Angina, Unstable; Coronary Artery Bypass; Humans; Isoquinolines; Male; Middle Aged; Myocardial Infarction; Neuromuscular Nondepolarizing Agents; Norepinephrine; Postoperative Complications; Propanolamines; Propofol; Thyroid Crisis; Thyroid Hormones; Thyrotoxicosis | 1994 |
Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiopulmonary Bypass; Dogs; Heart Rate; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Propanolamines | 1996 |
Repair of postinfarction ventricular septal defect on a beating heart.
Topics: Adrenergic beta-Antagonists; Aged; Body Temperature; Cardiopulmonary Bypass; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines; Shock, Cardiogenic; Ventricular Septal Rupture | 1996 |
Acquired dynamic left ventricular outflow tract obstruction complicating acute anterior myocardial infarction: serial echocardiographic and clinical evaluation.
Topics: Adrenergic beta-Antagonists; Aged; Echocardiography; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Myocardial Contraction; Myocardial Infarction; Propanolamines; Stroke Volume; Ventricular Function, Left; Ventricular Outflow Obstruction; Ventricular Pressure | 1997 |
Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol. A word of caution.
Topics: Adrenergic beta-Antagonists; Blood; Coronary Artery Bypass; Heart Defects, Congenital; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Myocardial Infarction; Myocardial Reperfusion; Postoperative Complications; Propanolamines; Treatment Outcome | 1998 |
Esmolol and cardiopulmonary bypass during reperfusion reduce myocardial infarct size in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Biopsy; Cardiopulmonary Bypass; Dogs; Female; Male; Microscopy, Electron; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Propanolamines | 2001 |
Autonomic manipulation influences both temporal and frequency analyses of late potentials.
Topics: Adrenergic beta-Antagonists; Atropine; Electrocardiography; Female; Heart Conduction System; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction; Propanolamines; Signal Processing, Computer-Assisted | 1992 |
Hypertensive crisis during coronary vessel surgery.
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Humans; Hypertension; Intraoperative Period; Myocardial Infarction; Nifedipine; Nitroprusside; Propanolamines; Vasoconstrictor Agents | 1989 |
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Coronary Disease; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Time Factors | 1985 |
Pharmacology and pharmacokinetics of esmolol.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Catecholamines; Coronary Circulation; Dogs; Heart; Heart Conduction System; Hemodynamics; Hindlimb; Kinetics; Myocardial Infarction; Oxygen Consumption; Propanolamines; Regional Blood Flow; Tissue Distribution | 1986 |